S&P 500
(0.27%) 5 475.09 points
Dow Jones
(0.13%) 39 170 points
Nasdaq
(0.83%) 17 879 points
Oil
(0.04%) $83.41
Gas
(0.16%) $2.48
Gold
(0.12%) $2 341.80
Silver
(1.52%) $29.75
Platinum
(0.40%) $992.70
USD/EUR
(0.05%) $0.931
USD/NOK
(0.16%) $10.66
USD/GBP
(0.04%) $0.791
USD/RUB
(0.00%) $86.75

Realtime updates for Seattle Genetics Inc [SGEN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated13 Dec 2023 @ 16:00

-0.07% $ 228.74

Live Chart Being Loaded With Signals

Commentary (13 Dec 2023 @ 16:00):
Profile picture for Seattle Genetics Inc

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer...

Stats
Today's Volume 19.39M
Average Volume 1.63M
Market Cap 43.15B
EPS $-1.150 ( Q3 | 2023-11-01 )
Next earnings date ( $0 ) 2024-07-31
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -57.19
(Sector) 42.63
(Industry) 24.32
ATR14 $1.424 (0.62%)
AADI -2.74%
ABCL -6.08%
ABCM 0.04%
ABEO -0.94%
ABIO -0.78%
ABOS -1.45%
ABSI -2.27%
ABUS 0.97%
ABVX 2.57%
ACAD -1.29%
ACER -17.95%
ACET -4.96%
ACGN 1.29%
ACHL -1.60%
ACHV 1.70%
ACIU -0.25%
ACLX -2.88%
ACRV 1.03%
ACST -2.34%
ACXP -4.89%
ADAG -0.33%
ADAP 7.70%
ADGI 0.87%
ADIL -5.22%
ADMA 3.31%
ADPT -0.55%
ADTX 14.49%
ADVM 1.60%
ADXN -12.26%
AEON -0.95%
AEZS 3.07%
AFMD -0.73%
AGEN -0.36%
AGIO 0.60%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -2.51%
AKRO -1.28%
AKTX 15.23%
AKUS 0.00%
ALBO 0.00%
ALDX -1.81%
ALEC -2.64%
ALGS 5.43%
ALKS 1.20%
ALLK -12.02%
ALLO 0.00%
ALLR 6.44%
ALNA 3.16%
ALNY 0.13%
ALPN 0.02%
ALPX 0.00%
ALRN 1.08%
ALT 8.27%
ALVR 0.93%
ALXN 0.00%
ALXO -0.66%
ALZN 0.91%
AMRN -0.29%
AMTI -3.13%
ANAB -1.80%
ANEB -1.83%
ANGN 0.00%
ANIX 0.45%
ANL -6.05%
ANNX 3.06%
ANPC -3.15%
APGE -1.96%
APGN 8.48%
APGNW 30.65%
APLM 0.96%
APLS -5.40%
APLT -1.28%
APM -7.51%
APOP 0.38%
APRE -0.98%
APTO -1.51%
APTX 3.17%
APVO 9.15%
ARAV -13.39%
ARCT -2.83%
ARDS 19.76%
ARDX 2.16%
ARGX 0.97%
ARNA 0.00%
ARPO -0.90%
ARQT 2.80%
ARTL -3.57%
ARTLW 0.00%
ARVN -2.40%
ARWR 0.23%
ASLN 0.00%
ASMB -3.50%
ASND -1.76%
ATAI 1.50%
ATHA -5.28%
ATHE 0.00%
ATHX -33.50%
ATNF -7.98%
ATOS 0.84%
ATRA -1.65%
ATXI -2.86%
ATXS 1.65%
AUPH -3.85%
AURA -2.51%
AUTL -0.29%
AVBP -2.16%
AVEO 0.00%
AVIR 1.81%
AVRO -1.41%
AVTE 2.41%
AVTX 1.12%
AVXL -2.61%
AXLA 0.00%
AXSM 0.66%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -0.51%
BCAB -1.46%
BCDA 0.67%
BCDAW 0.00%
BCEL 0.00%
BCLI 5.47%
BCRX 7.93%
BCTX -4.39%
BCTXW 17.17%
BCYC 0.25%
BDRX -0.23%
BDTX 0.86%
BEAM -1.62%
BFRA -2.91%
BGNE 1.56%
BIOR -4.56%
BIVI 4.00%
BLCM -6.68%
BLI -5.88%
BLPH -1.93%
BLRX -1.06%
BLTE 0.31%
BLU 0.03%
BLUE -0.90%
BMEA -1.78%
BMRN -0.24%
BNOX -10.04%
BNTC 3.92%
BNTX -1.90%
BOLD 8.27%
BOLT -2.41%
BPMC 1.30%
BPTH -3.00%
BPTS -13.47%
BRNS 2.14%
BRTX -2.46%
BTAI -8.59%
BTTX -15.97%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.92%
CABA 4.41%
CADL 1.61%
CALA 0.00%
CALC 7.32%
CALT -0.62%
CAPR 1.47%
CARA 1.94%
CARM 9.87%
CASI -1.82%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.89%
CCCC 4.98%
CCXI 0.00%
CDAK 0.00%
CDIO -1.82%
CDIOW 6.00%
CDMO -0.28%
CDMOP 0.04%
CDT -6.12%
CDTTW 72.08%
CDTX 0.84%
CDXC -1.47%
CDXS -3.55%
CELC 1.59%
CELU 1.92%
CELUW 1.32%
CERC -1.68%
CERE 1.13%
CERO -8.16%
CEROW 43.57%
CFRX -27.95%
CGEM -4.07%
CGEN 4.17%
CGON 0.48%
CGTX 0.60%
CHMA -6.00%
CHRS -6.94%
CINC 0.00%
CING 7.50%
CINGW 4.85%
CKPT -4.65%
CLBS -16.75%
CLDX 5.35%
CLGN 1.00%
CLLS 3.48%
CLNN 0.22%
CLNNW 44.05%
CLRB 2.00%
CLSD -4.62%
CLSN -0.68%
CLVS 0.00%
CMMB 5.00%
CMND -1.19%
CMPI 0.00%
CMPX -5.45%
CMRA 0.00%
CMRAW 33.33%
CMRX -0.80%
CNCE 0.00%
CNSP -10.13%
CNST 0.00%
CNTA -2.55%
CNTB -5.26%
CNTX -9.73%
COCP 3.00%
COEPW 0.00%
COGT 6.05%
CORT 0.55%
COYA 0.66%
CPRX 1.81%
CRBP 9.17%
CRBU -3.05%
CRDF -7.66%
CRGX -2.56%
CRIS -7.54%
CRNX 2.86%
CRSP -0.11%
CRTX 2.63%
CRVO -5.84%
CRVS 1.65%
CSBR -4.26%
CTCX 23.31%
CTIC 0.06%
CTMX 9.02%
CTNM 19.25%
CTXR -6.92%
CUE -17.74%
CVAC -2.06%
CVKD -1.15%
CWBR 0.00%
CYAD -12.96%
CYCC 0.00%
CYCCP -11.68%
CYCN 0.88%
CYT -2.27%
CYTK 0.96%
CYTO 9.91%
DARE -6.03%
DAWN -1.45%
DBTX -0.81%
DBVT 2.20%
DFFN 10.28%
DICE 0.06%
DMAC 0.00%
DNLI -5.21%
DNTH 11.55%
DOMH 4.81%
DRMA -5.37%
DRMAW 7.69%
DRNA 0.00%
DRTS 0.79%
DRTSW 19.05%
DRUG -2.77%
DSGN -2.99%
DTIL 1.64%
DYAI 3.38%
EARS -1.77%
EDIT -1.28%
EDSA 2.09%
EFTR -8.00%
EFTRW -41.67%
EIGR -9.21%
ELAB 0.07%
ELDN -4.92%
ELEV 5.93%
ELOX 1.45%
ELTX -8.03%
ELVN -2.87%
ELYM -0.84%
ENGN -4.03%
ENGNW -2.88%
ENLV -2.82%
ENOB 1.79%
ENSC -1.23%
ENTA 0.77%
ENTO -11.11%
ENTX -4.35%
ENVB -5.90%
EPIX -2.66%
EPRX 2.38%
EPZM 0.00%
EQ -2.21%
EQRX -2.09%
EQRXW 0.00%
ERAS 3.39%
ERNA 4.14%
ERYP 1.30%
ESLA 4.76%
ESLAW 0.00%
ETNB -3.12%
ETON 3.34%
ETTX 0.00%
EVAX 0.70%
EVGN -0.91%
EVLO 39 899.32%
EWTX 7.61%
EXAI 0.98%
EXEL -0.98%
EYEG -0.51%
EYEN 14.27%
EYPT -4.48%
FATE -0.61%
FBIO -1.17%
FBIOP 0.70%
FBLG -19.84%
FBRX 1.68%
FDMT 1.67%
FENC 2.62%
FGEN -13.69%
FHTX 1.57%
FIXX 0.77%
FMTX 0.00%
FNCH -10.95%
FOLD -1.21%
FREQ 4.76%
FRLN 0.15%
FRTX -4.21%
FSTX 0.00%
FTRE 2.23%
FULC 1.77%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.98%
GANX -12.50%
GBIO -8.87%
GBT 0.01%
GDTC -0.99%
GERN 2.36%
GHRS 0.77%
GLMD -1.01%
GLPG 0.93%
GLSI -2.84%
GLTO -1.73%
GLUE 5.35%
GLYC 5.15%
GMAB -1.11%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 10.80%
GNLX -5.64%
GNPX 2.39%
GNTA -0.87%
GOSS 5.18%
GOVX 2.98%
GOVXW -10.37%
GPCR 1.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -6.13%
GRTX -8.63%
GTHX 8.33%
GUTS 4.45%
GXGXW 41.67%
GYRE 0.92%
HALO -0.65%
HARP 0.09%
HCWB 0.46%
HEPA -0.93%
HGEN -84.62%
HILS 5.66%
HLVX -0.28%
HOOK 6.17%
HOTH -1.12%
HOWL -3.69%
HRMY 0.83%
HRTX -0.86%
HSTO 0.00%
HUMA 11.88%
HUMAW 22.30%
IBRX -0.79%
ICCC -8.04%
ICPT 0.21%
ICU 23.06%
ICUCW 13.26%
ICVX -0.91%
IDRA -23.04%
IDYA 2.31%
IFRX -1.72%
IGMS -1.16%
IKNA 0.00%
IKT -5.34%
IMAB -2.99%
IMCR 7.49%
IMGN 0.02%
IMGO 0.00%
IMMP 0.00%
IMMX 7.07%
IMNM 0.83%
IMNN 8.62%
IMPL -27.27%
IMRA 15.96%
IMRN -9.26%
IMRX -8.59%
IMTX 3.27%
IMTXW 27.41%
IMUX 0.90%
IMV 0.00%
IMVT 4.20%
INAB -3.95%
INBX -3.03%
INCY 0.41%
INDP 4.25%
INFI -52.38%
INKT -3.51%
INM -5.24%
INMB -4.54%
INO 6.56%
INSM -0.99%
INTS 0.41%
INVA 0.61%
INZY -1.12%
IOBT -4.27%
IONS -1.15%
IOVA 0.50%
IPA -3.71%
IPHA 7.22%
IPSC -5.49%
IRON 3.11%
ISEE 0.38%
ITOS 1.15%
ITRM -5.60%
IVA -1.19%
IVVD 9.09%
JAGX -2.79%
JANX -0.41%
JAZZ -0.24%
JNCE 0.00%
JSPR 1.94%
JSPRW 5.15%
JUNS 0.00%
JUNSW 0.00%
KA 4.20%
KALV 0.93%
KDNY 0.22%
KMPH -0.34%
KNSA -3.59%
KNTE -0.38%
KOD 0.85%
KPRX 3.57%
KPTI -6.01%
KRBP -1.83%
KRON -9.68%
KROS -4.22%
KRRO -0.06%
KRTX 0.03%
KRYS -0.75%
KTRA 10.14%
KTTA 0.38%
KTTAW 1.83%
KURA 2.96%
KYMR 3.69%
KYTX 4.13%
KZIA -4.91%
KZR -2.73%
LABP 0.57%
LBPH 14.39%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.91%
LENZ 2.31%
LEXX -0.72%
LEXXW 23.90%
LGND 0.70%
LGNDV 0.00%
LGVN -2.48%
LIAN -8.28%
LIFE 2.70%
LIPO -3.41%
LIXT -0.38%
LIXTW -3.71%
LJPC -0.32%
LMNL 0.12%
LOGC -3.15%
LPCN -6.31%
LPTX -4.59%
LQDA 0.33%
LRMR 13.66%
LSTA 2.31%
LTRN -3.21%
LUMO -2.46%
LVTX 3.89%
LXEO -2.68%
LXRX -0.30%
LYEL 8.97%
LYRA 7.30%
MACK 0.10%
MBIO 2.41%
MBRX -1.15%
MCRB -0.25%
MDGL -0.30%
MDNA -13.16%
MDWD -0.84%
MDXG -3.32%
MEIP -2.06%
MESO -0.44%
MGNX 1.18%
MGTA -7.74%
MGTX -2.61%
MGX 8.33%
MIRM -0.09%
MIRO 0.59%
MIST 0.75%
MITO 0.00%
MLEC -0.88%
MLECW -31.50%
MLND -5.36%
MLTX -4.94%
MLYS 4.02%
MNKD -2.49%
MNMD -1.94%
MNOV 0.00%
MNPR -0.88%
MOLN 2.80%
MOR -0.22%
MORF -4.46%
MREO 0.83%
MRKR -0.74%
MRNA -2.36%
MRNS 9.40%
MRSN -1.99%
MRTX -0.17%
MRUS -7.98%
MRVI -3.07%
MTCR -1.29%
MTEM 2.61%
MTP -18.50%
MURA -0.96%
MYMD 0.00%
NAMS 7.13%
NAMSW -4.76%
NAUT -2.99%
NBRV 0.71%
NBSE -1.56%
NBTX 7.00%
NCNA 7.36%
NERV -0.86%
NEXI -6.90%
NGM -1.28%
NGNE 11.62%
NKGN 0.00%
NKGNW -12.00%
NKTR -1.61%
NKTX -1.02%
NLSP -9.50%
NLSPW 26.58%
NMRA 1.12%
NMTR -42.97%
NOVN -24.84%
NRBO -6.20%
NRIX 0.19%
NRSN -3.57%
NRSNW -2.91%
NRXP 5.74%
NRXPW 41.43%
NRXS 1.44%
NTBL -6.12%
NTEC -12.45%
NTHI 0.00%
NTLA 0.40%
NTRBW 74.65%
NUVL -0.46%
NVAX 0.55%
NVCT -2.37%
NVIV -34.28%
NXTC -5.66%
NYMX -0.05%
OABI -0.27%
OABIW -9.28%
OBIO -12.64%
OBSV 0.00%
OCEA -3.28%
OCGN 4.84%
OCS -0.50%
OCUL -2.63%
OCUP 3.92%
ODT -4.27%
OKYO 1.64%
OLMA 2.96%
OMER -2.71%
OMGA 8.70%
ONCO -6.10%
ONCR -3.08%
ONCS 31.87%
ONCT -7.70%
ONCY 0.53%
ONTX -0.47%
ONVO -0.34%
OPNT 0.00%
OPT -0.99%
ORGS 8.13%
ORIC 8.06%
ORMP -0.39%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.41%
OVID 12.09%
OYST 0.00%
PALI -5.29%
PASG 11.43%
PBLA -10.00%
PBM 6.33%
PBYI 0.61%
PCSA -7.11%
PCVX 1.89%
PDSB 3.41%
PEPG 12.22%
PGEN -1.90%
PHAR -4.62%
PHAS 0.00%
PHAT 4.95%
PHIO -3.88%
PHIOW 36.47%
PHVS -0.59%
PHXM -5.20%
PIRS -1.82%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 1.02%
PLUR -0.43%
PMN 6.67%
PMVP -2.47%
PNT 0.16%
PPBT -13.47%
PRAX -0.41%
PRDS 0.93%
PRLD -1.05%
PROG -3.47%
PROK 1.63%
PRQR -0.60%
PRTA -0.78%
PRTC 3.68%
PRTG -7.63%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 2.04%
PSTX 3.08%
PTCT 1.93%
PTE -0.82%
PTGX 1.59%
PTIXW -48.41%
PULM 1.55%
PXMD -1.27%
PYPD -0.24%
PYXS -3.32%
QLGN -3.77%
QNCX -3.33%
QNRX 1.75%
QSI -11.01%
QSIAW 4.08%
QTTB 5.74%
QURE -0.78%
RAIN -1.63%
RANI 0.53%
RAPT -5.57%
RARE 0.05%
RCKT -4.04%
REGN 0.57%
RENB -10.86%
REPL 4.00%
RETA 0.02%
REUN -0.89%
REVB -1.58%
REVBU 3.46%
REVBW 0.00%
RGLS 6.44%
RGNX -5.38%
RIGL 2.31%
RLAY -1.84%
RLMD 2.33%
RLYB 1.49%
RNA 1.05%
RNAC -10.14%
RNAZ -4.54%
RNXT 1.77%
ROIV 2.46%
ROIVW 4.56%
RPHM 2.65%
RPRX -0.68%
RPTX 0.91%
RUBY 2.70%
RVLP -32.05%
RVMD 0.00%
RVMDW -1.40%
RVNC 0.00%
RVPH -7.03%
RVPHW 4.88%
RXDX 0.09%
RXRX -0.53%
RYTM 3.92%
RYZB 0.02%
RZLT 0.23%
SABS -1.94%
SABSW 54.57%
SAGE 1.57%
SANA 0.18%
SAVA -1.70%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.16%
SCPH -0.69%
SCPS 0.00%
SEEL 3.69%
SEER 0.60%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -7.90%
SGMT -7.60%
SGTX -2.56%
SIOX 22.63%
SLDB 10.58%
SLGL -4.21%
SLN -1.37%
SLNO 3.65%
SLRX -7.92%
SLS -0.84%
SMMT 4.36%
SNDX 4.87%
SNGX -4.26%
SNPX 1.97%
SONN -0.80%
SPPI -0.49%
SPRB 2.55%
SPRC -5.98%
SPRO -1.54%
SRNE -20.00%
SRPT -0.79%
SRRA 0.00%
SRRK -2.40%
SRZN -2.28%
STAB 0.00%
STOK 2.66%
STRO 4.10%
STSA 0.00%
STTK 3.37%
SURF -0.93%
SVRA 15.14%
SWTX 2.28%
SYBX -0.67%
SYRS -4.46%
TALS -0.73%
TARA 0.48%
TARS 3.90%
TBPH 0.47%
TCBP 1.76%
TCDA 0.00%
TCON -30.63%
TCRR 0.00%
TCRT -6.87%
TCRX 1.37%
TECH -0.06%
TENX -1.32%
TERN 0.59%
TFFP 7.23%
TGTX 2.02%
THRX 0.12%
TIL 0.10%
TLC 0.00%
TLSA -3.63%
TNGX 4.90%
TNXP 4.96%
TNYA 8.71%
TPST -2.28%
TRDA 0.49%
TRVI -3.02%
TRVN -3.81%
TSHA 0.89%
TSVT 5.19%
TTNP -0.18%
TVTX 0.73%
TYRA 8.07%
UBX -1.48%
UNCY 7.76%
URGN -1.79%
UTHR 0.14%
VACC 11.36%
VALN -3.27%
VAXX 20.24%
VBIV 4.85%
VBLT -8.77%
VCEL -1.85%
VCNX -0.15%
VCYT -1.57%
VERA 0.30%
VERU 4.45%
VERV 2.05%
VIGL 9.25%
VINC -6.26%
VIR 2.25%
VIRI 3.26%
VIRX -6.20%
VKTX 4.36%
VLON -13.04%
VNDA -1.24%
VOR -1.07%
VRCA 9.05%
VRDN 1.54%
VRNA 7.26%
VRPX -1.59%
VRTX 0.54%
VSTM 9.06%
VTGN 2.59%
VTVT -0.42%
VTYX -2.16%
VXRT 3.19%
VYGR -0.63%
VYNE -2.54%
VYNT 7.78%
WINT 0.00%
WVE 4.91%
XBIO -0.48%
XBIT 7.98%
XCUR -3.93%
XENE -3.33%
XERS -3.56%
XFOR 1.62%
XLO -2.49%
XLRN 0.00%
XNCR 0.48%
XOMA 5.11%
XOMAO 0.20%
XOMAP 1.98%
XRTX -1.06%
YMAB -2.07%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -0.23%
ZNTL 2.45%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-12-14 Baker Bros. Advisors Lp Sell 42 977 301 Common Stock
2023-12-14 Baker Bros. Advisors Lp Sell 8 750 Stock Options (right to buy)
2023-12-14 Baker Bros. Advisors Lp Sell 9 260 Stock Options (right to buy)
2023-12-14 Baker Bros. Advisors Lp Sell 9 260 Stock Options (right to buy)
2023-12-14 Baker Bros. Advisors Lp Sell 9 260 Stock Options (right to buy)
INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 | Sell: 44 783 214

Volume Correlation

Long: 0.24 (neutral)
Short: 0.00 (neutral)
Signal:(82.918) Neutral

Seattle Genetics Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Seattle Genetics Inc Correlation - Currency/Commodity

The country flag -0.55
( weak negative )
The country flag -0.35
( neutral )
The country flag -0.69
( moderate negative )
The country flag 0.03
( neutral )
The country flag 0.83
( strong )
The country flag 0.32
( neutral )

Seattle Genetics Inc Financials

Annual 2022
Revenue: $1.96B
Gross Profit: $1.55B (79.10 %)
EPS: $-3.30
FY 2022
Revenue: $1.96B
Gross Profit: $1.55B (79.10 %)
EPS: $-3.30
FY 2021
Revenue: $1.57B
Gross Profit: $1.26B (80.21 %)
EPS: $-3.70
FY 2020
Revenue: $2.18B
Gross Profit: $1.96B (89.99 %)
EPS: $3.51

Financial Reports:

No articles found.

Seattle Genetics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Seattle Genetics Inc

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 6.3546741008759 seconds
Number of API calls: 3
Number of DB calls: 9